1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An Immunoscore Using PD-L1, CD68, and Tumor-infiltrating Lymphocytes (TILs) to Predict Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer. Issue 9 (October 2018) Authors: McLemore, Lauren E.; Janakiram, Murali; Albanese, Joseph; Shapiro, Nella; Lo, Yungtai; Zang, Xingxing; Fineberg, Susan Journal: Applied immunohistochemistry & molecular morphology Issue: Volume 26:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. B7 immune-checkpoints as targets for the treatment of neuroendocrine tumors. Issue 2 (February 2021) Authors: Yuan, Ziqiang; Gardiner, Juliet C; Maggi, Elaine C; Huang, Shuyu; Adem, Asha; Bagdasarov, Svetlana; Li, Guiying; Lee, Sylvia; Slegowski, Daniel; Exarchakis, Alyssa; Howe, James R; Lattime, Edmund C; Zang, Xingxing; Libutti, Steven K Journal: Endocrine-related cancer Issue: Volume 28:Issue 2(2021) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Co-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?. (16th November 2016) Authors: Liu, Weifeng; Almo, Steven C.; Zang, Xingxing Journal: Immunological investigations Issue: Volume 45:Number 8(2016) Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Curcumin improves the therapeutic efficacy of Listeriaat‐Mage‐b vaccine in correlation with improved T‐cell responses in blood of a triple‐negative breast cancer model 4T1. (2nd July 2013) Authors: Singh, Manisha; Ramos, Ilyssa; Asafu‐Adjei, Denise; Quispe‐Tintaya, Wilber; Chandra, Dinesh; Jahangir, Arthee; Zang, Xingxing; Aggarwal, Bharat B.; Gravekamp, Claudia Journal: Cancer medicine Issue: Volume 2:Number 4(2013:Aug.) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. (November 2015) Authors: Assal, Amer; Kaner, Justin; Pendurti, Gopichand; Zang, Xingxing Journal: Immunotherapy Issue: Volume 7:Number 11(2015:Nov.) Page Start: 1169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Histone deacetylases inhibitor MS‐275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway. Issue 12 (23rd May 2019) Authors: Ma, Shanshan; Liu, Tengfei; Xu, Ling; Wang, Yaping; Zhou, Jiankang; Huang, Tuanjie; Li, Peng; Liu, Hongtao; Zhang, Yanting; Zhou, Xinkui; Cui, Yuanbo; Zang, Xingxing; Wang, Yuming; Guan, Fangxia Journal: Journal of cellular physiology Issue: Volume 234:Issue 12(2019:Dec.) Page Start: 22400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Issue 1 (January 2015) Authors: Ohaegbulam, Kim C.; Assal, Amer; Lazar-Molnar, Eszter; Yao, Yu; Zang, Xingxing Journal: Trends in molecular medicine Issue: Volume 21:Issue 1(2015) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗